Login to Your Account



Bavarian's Smallpox Vaccine Pact Worth Up To $1.6 Billion

By Cormac Sheridan


Wednesday, June 6, 2007
Bavarian Nordic A/S could earn a total of $1.6 billion from its contract with the U.S. Department of Health and Human Services to supply a stockpile of next-generation safe smallpox vaccines. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription